SHANNON REYNOLDS: Open Payments
NPI 1194133348 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 25 payments from 12 companies in 2025. Trend: 2023 $594 · 2024 $578 · 2025 $506
Food & beverage: $504Education: $2
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $66 |
| Aurinia Pharma U.S., Inc. | 2 | $43 |
| Travere Therapeutics, Inc. | 3 | $42 |
| Calliditas Therapeutics US Inc. | 2 | $41 |
| Amgen Inc. | 2 | $36 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Vifor Pharma, Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $23 |
Products named: Fabhalta, Kerendia, JYNARQUE, LUPKYNIS, TARPEYO, KRYSTEXXA, FUROSCIX, Veltassa.
Industry payments across GA — which companies pay providers there.
